BSECompany Update28 Aug 2026 · 28 Aug 2026, 10:58 pm
Outcome of the Fund Raising Committee held on 28.08.2026 for allotment of equity shares through QIP
Gujarat Themis Biosyn Ltd · 506879
✦ AI Summary▲ PositiveFundraise
Gujarat Themis Biosyn Ltd has announced the outcome of the Fund Raising Committee meeting held on August 28, 2026, for the allotment of equity shares through a Qualified Institutions Placement (QIP). The committee approved the issue and allotment of 2,11,86,440 equity shares at an issue price of Rs. 354 per equity share, aggregating to Rs. 749,99,99,760. The paid-up equity share capital of the company stands increased from Rs. 10,89,65,265 to Rs. 13,01,51,705.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Allotment
Attachments (1)
📄pdf
Download →
f4ccb1aa-e850-491c-b115-f2605a8f889d.pdf
View document text
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TEL: 0260-2430027 / 2400639, E-mail: hrm@gtbl.in.net
August 28, 2026
Listing Department Department of Corporate Services
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street
Bandra Kurla Complex Mumbai - 400001
Bandra East, Mumbai 400051
Symbol: GUJTHEM Scrip Code: 506879
Dear Sir/Madam,
Re: Qualified institutions placement (“QIP” or “Issue”) of equity shares of face value of
Rs. 1 each (the “Equity Shares”) to qualified institutional buyers (“QIBs”)
Sub: Outcome of the meeting of the Fund-Raising Committee.
In furtherance to our earlier intimation with respect to the Issue which opened on August 25, 2026
and closed on August 28, 2026, we wish to inform you that the Fund Raising Committee of the
Company at its meeting held today, i.e. August 28, 2026, approved the issue and allotment of
2,11,86,440 Equity Shares, to eligible QIBs at the issue price of Rs. 354 per Equity Share
(including a premium of Rs. 353 per Equity Share), which includes a discount of Rs. 18.57 ie
4.98% of the floor price, as determined in terms of SEBI ICDR Regulations)], aggregating to
Rs. 749,99,99,760, pursuant to the QIP.
Pursuant to the allotment of Equity Shares under the QIP, the paid-up equity share capital of the
Company stands increased from Rs. 10,89,65,265 consisting of 10,89,65,265 Equity Shares of face
value of Rs. 1 each to Rs. 13,01,51,705 consisting of 13,01,51,705 Equity Shares of face value of
Rs. 1 each. The shareholding pattern of the Company before and after the Issue, will be submitted
along with listing application in the format specified in Regulation 31 of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The information as required under Regulation 30 of the SEBI Listing Regulations read with
Schedule – III part- A to the SEBI Listing Regulations to read with the Securities and Exchange
Board of India circular no. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023, SEBI
master circular no. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 is as
follows:
Type of securities issued and allotted (viz. equity Equity Shares
shares, convertibles etc.)
Type of issuance (further public offering, rights Qualified Institutions Placement
issue, depository receipts (ADR/GDR), qualified
institutions placement, preferential allotment etc.)
GUJARAT THEMIS
BIOSYN LIMITED
Total no. of securities issued or the total amount 2,11,86,440 Equity Shares at an issue price
for which the securities have been issued of Rs. 354 per Equity Share (including a
(approximately) p remium of Rs. 353 per Equity Share).
Total amount for which securities were issued Rs. 749,99,99,760/-
The Fund-Raising Committee meeting commenced at 10:15 p.m. and the meeting was concluded
at 10:30 p.m.
Further find attached herewith the list of allottees who have been allotted more than 5 per cent of
the Equity Shares of the Issue size marked as Annexure A.
We request you to take the above on record pursuant to compliance under SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Thanking you
Yours faithfully
For Gujarat Themis Biosyn Limited
Vineet Gawankar
Company Secretary & Compliance Officer
Encl.: As above
GUJARAT THEMIS
BIOSYN LIMITED
Annexure A
LIST OF ALLOTTEES WHO HAVE BEEN ALLOTTED MORE THAN 5 PER CENT OF
THE EQUITY SHARES OFFERED IN THE QIP
No. of
Sr % of Total
Name of the Allottees Shares Category
No Issue
Allotted
QUANT MUTUAL FUND - QSIF EQUITY EX TOP
1 15,00,000 7.08% MUTUAL FUND - MF
100 LONG-SHORT FUND
QUANT MUTUAL FUND - QSIF HYBRID LONG-
2 5,75,100 2.71% MUTUAL FUND - MF
SHORT FUND
QUANT MUTUAL FUND - QSIF ACTIVE ASSET
3 7,50,000 3.54% MUTUAL FUND - MF
ALLOCATOR LONG - SHORT FUND
QUANT MUTUAL FUND - QSIF SECTOR
4 93,000 0.44% MUTUAL FUND - MF
ROTATION LONG - SHORT FUND
QUANT MUTUAL FUND - QUANT EQUITY
5 1,18,644 0.56% MUTUAL FUND - MF
SAVINGS FUND
QUANT MUTUAL FUND - QUANT SMALL CAP
6 54,37,833 25.67% MUTUAL FUND - MF
FUND
INSURANCE COMPANY
KOTAK MAHINDRA LIFE INSURANCE
7 28,24,859 13.33% REGISTERED WITH
COMPANY LTD.
IRDAI
BANK OF INDIA MANUFACTURING &
8 2,82,486 1.33% MUTUAL FUND - MF
INFRASTRUCTURE FUND
9 BANK OF INDIA SMALL CAP FUND 8,47,458 4.00% MUTUAL FUND - MF
10 BANK OF INDIA FLEXI CAP FUND 7,06,215 3.33% MUTUAL FUND - MF
11 BANK OF INDIA MULTI CAP FUND 2,82,486 1.33% MUTUAL FUND - MF
12 CAPRI GLOBAL CAPITAL LIMITED 14,12,430 6.67% SI - NBFC
FOREIGN PORTFOLIO
13 SAINT CAPITAL FUND 11,29,944 5.33% INVESTOR
(CORPORATE)
FOREIGN PORTFOLIO
14 AYUSHMAT LTD 24,01,130 11.33%
INVESTOR (CORPORATE)
For Gujarat Themis Biosyn Limited
Vineet Gawankar
Company Secretary & Compliance Officer